Ceftazidime

C. diff Risk

High

Oral Bioavailability

NA

Spectrum Of Activity

Dosing

2 g IV q8h

50+ mL/min10 - 50 mL/min0 - 10 mL/min2 g IV q8h2 g IV q12-24h2 g IV q24-48h

Give dose after dialysis on dialysis days2 g IV qHD

2 g IV q12h

1 g IV once, then 500 mg IV q24h

General Information

Adverse Effects

Allergy/rash (immediate or delayed).

Can cause positive Coombs, cytopenias, eosinophilia, and hepatic and renal laboratory abnormalities

Pharmacology

Antimicrobial class: 3rd generation Cephalosporin

Pregnancy category: B